• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    District Court Denies Request to Enjoin Acquisition of Change Healthcare Inc. by UnitedHealth Group Incorporated: Change Healthcare Inc: Announces Special Cash Dividend

    9/20/22 5:15:00 PM ET
    $CHNG
    $UNH
    Managed Health Care
    Health Care
    Medical Specialities
    Health Care
    Get the next $CHNG alert in real time by email

     

    Yesterday, the U.S. District Court for the District of Columbia issued an opinion and final appealable order denying the request made by the U.S. Department of Justice and the States of New York and Minnesota for the Court to enjoin UnitedHealth Group Incorporated (NYSE:UNH) ("UnitedHealth Group") from acquiring Change Healthcare Inc. (NASDAQ:CHNG) (the "Company" or "Change Healthcare") pursuant to the proposed merger (the "Merger") between the Company and a wholly owned subsidiary of UnitedHealth Group, which will result in the combination of the Company and Optum Insight, a part of UnitedHealth Group. The opinion and final appealable order also require UnitedHealth Group and the Company to divest ClaimsXten to TPG Capital as proposed by UnitedHealth Group and the Company.

    Today, the Company announced that it has declared a one-time special dividend of $2.00 in cash per each issued and outstanding share of common stock of the Company. The special dividend will be paid to stockholders of record of the Company's common stock as of immediately prior to the effective time of the Merger which pursuant to Nasdaq requirements will occur no less than ten (10) days from today, subject to the satisfaction of closing conditions. The special dividend will be payable on or about the first business day following the closing of the Merger.

    About Change Healthcare

    Change Healthcare is a leading healthcare technology company, focused on insights, innovation, and accelerating the transformation of the U.S. healthcare system through the power of the Change Healthcare platform. Change Healthcare provides data and analytics-driven solutions to improve clinical, financial, administrative, and patient engagement outcomes in the U.S. healthcare system. Learn more at changehealthcare.com.

    Forward Looking Statements

    This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 with respect to the financial condition, results of operations and businesses of Change Healthcare. Some of these statements can be identified by terms and phrases such as "anticipate," "believe," "intend," "estimate," "expect," "continue," "could," "should," "may," "plan," "project," "predict" and similar expressions. Change Healthcare cautions readers of this press release that such "forward looking statements," including without limitation, those relating to the timing of the proposed merger, the one-time cash dividend and Change Healthcare's future business prospects, revenue, working capital, liquidity, capital needs, interest costs and income, wherever they occur in this press release or in other statements attributable to Change Healthcare, are necessarily estimates reflecting the judgment of Change Healthcare's senior management and involve a number of risks and uncertainties that could cause actual results to differ materially from those suggested by the "forward looking statements."

    Factors that could cause Change Healthcare's actual results to differ materially from those expressed or implied in such forward-looking statements include, but are not limited to, the inability to complete the proposed merger due to the failure to satisfy the conditions to the completion of the proposed merger, including that a governmental entity may prohibit, delay or refuse to grant approval for the consummation of the transaction; risks related to disruption of management's attention from Change Healthcare's ongoing business operations due to the transaction; the effect of the announcement of the proposed merger on Change Healthcare's operations, results and business generally; the risk that the proposed merger will not be consummated in a timely manner, exceeding the expected costs of the merger; the occurrence of any event, change or other circumstances that could give rise to the termination of the merger agreement; macroeconomic and industry trends and adverse developments in the debt, consumer credit and financial services markets; uncertainty and risks related to the impact of the COVID-19 pandemic (including the rise of COVID-19 variant strains such as the Delta and Omicron variants) on the national and global economy, Change Healthcare's business, suppliers, customers, and employees; Change Healthcare's ability to retain and recruit key management personnel and other talent (including while the proposed merger is pending); Change Healthcare's ability to retain or renew existing customers and attract new customers; Change Healthcare's ability to connect a large number of payers and providers; Change Healthcare's ability to provide competitive services and prices while maintaining its margins; further consolidation in Change Healthcare's end-customer markets; Change Healthcare's ability to effectively manage its costs; Change Healthcare's ability to effectively develop and maintain relationships with its channel partners; Change Healthcare's ability to timely develop new services and improve existing solutions; Change Healthcare's ability to deliver services timely without interruption; a decline in transaction volume in the U.S. healthcare industry; Change Healthcare's ability to maintain access to its data sources; Change Healthcare's ability to maintain the security and integrity of its data; Change Healthcare's reliance on key management personnel; Change Healthcare's ability to manage and expand its operations and keep up with rapidly changing technologies; the ability of outside service providers and key vendors to fulfill their obligations to Change Healthcare; risks related to international operations; Change Healthcare's ability to protect and enforce its intellectual property, trade secrets and other forms of unpatented intellectual property; Change Healthcare's ability to defend its intellectual property from infringement claims by third parties; government regulation and changes in the regulatory environment; changes in local, state, federal and international laws and regulations, including related to taxation; economic and political instability in the U.S. and international markets where Change Healthcare operates; the economic impact of escalating global tensions, including the conflict between Russia and Ukraine, and the adoption or expansion of economic sanctions or trade restrictions; litigation or regulatory proceedings; losses against which Change Healthcare does not insure; Change Healthcare's ability to make acquisitions and integrate the operations of acquired businesses; Change Healthcare's ability to make timely payments of principal and interest on its indebtedness; Change Healthcare's ability to satisfy covenants in the agreements governing its indebtedness; Change Healthcare's ability to maintain liquidity; the potential dilutive effect of future issuance of shares of Change Healthcare's common stock; the impact of anti-takeover provisions in Change Healthcare's organizational documents and under Delaware law, which may discourage or delay acquisition attempts, and other risks. For a more detailed discussion of these factors, see the information under the captions "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in Change Healthcare's most recent Annual Report on Form 10-K filed with the Securities and Exchange Commission ("SEC") on May 26, 2022 as such factors may be updated from time to time in our periodic filings with the SEC.

    Change Healthcare's forward-looking statements speak only as of the date of this press release or as of the date they are made. Change Healthcare disclaims any intent or obligation to update any "forward looking statement" made in this press release to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results over time.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20220920006242/en/

    Get the next $CHNG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CHNG
    $UNH

    CompanyDatePrice TargetRatingAnalyst
    UnitedHealth Group Incorporated
    $UNH
    6/4/2026$450.00Neutral → Buy
    BofA Securities
    UnitedHealth Group Incorporated
    $UNH
    4/27/2026Hold → Buy
    Erste Group
    UnitedHealth Group Incorporated
    $UNH
    4/22/2026$400.00Hold → Buy
    Argus
    UnitedHealth Group Incorporated
    $UNH
    4/7/2026$300.00Reduce → Hold
    HSBC Securities
    UnitedHealth Group Incorporated
    $UNH
    4/1/2026$330.00Mkt Perform → Outperform
    Raymond James
    UnitedHealth Group Incorporated
    $UNH
    10/29/2025$333.00Buy → Hold
    Deutsche Bank
    UnitedHealth Group Incorporated
    $UNH
    10/14/2025$406.00Buy
    Goldman
    UnitedHealth Group Incorporated
    $UNH
    7/31/2025$198.00Neutral → Underperform
    Robert W. Baird
    More analyst ratings

    $CHNG
    $UNH
    SEC Filings

    View All

    UnitedHealth Group Incorporated filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    6/5/26 4:17:52 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form DEFA14A filed by UnitedHealth Group Incorporated

    DEFA14A - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    5/15/26 9:49:39 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Incorporated filed SEC Form 8-K: Regulation FD Disclosure

    8-K - UNITEDHEALTH GROUP INC (0000731766) (Filer)

    5/11/26 5:28:55 PM ET
    $UNH
    Medical Specialities
    Health Care

    $CHNG
    $UNH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    President & CFO Rex John F bought $4,999,919 worth of shares (17,175 units at $291.12), increasing direct ownership by 9% to 203,796 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:47 PM ET
    $UNH
    Medical Specialities
    Health Care

    CEO, UHG Hemsley Stephen J bought $25,019,019 worth of shares (86,700 units at $288.57), increasing direct ownership by 15% to 679,493 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 6:11:45 PM ET
    $UNH
    Medical Specialities
    Health Care

    Director Flynn Timothy Patrick bought $491,786 worth of shares (1,533 units at $320.80) (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    5/16/25 12:28:22 PM ET
    $UNH
    Medical Specialities
    Health Care

    $CHNG
    $UNH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    $CHNG
    $UNH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    UnitedHealth upgraded by BofA Securities with a new price target

    BofA Securities upgraded UnitedHealth from Neutral to Buy and set a new price target of $450.00

    6/4/26 8:41:44 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth upgraded by Erste Group

    Erste Group upgraded UnitedHealth from Hold to Buy

    4/27/26 9:46:23 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth upgraded by Argus with a new price target

    Argus upgraded UnitedHealth from Hold to Buy and set a new price target of $400.00

    4/22/26 7:35:11 AM ET
    $UNH
    Medical Specialities
    Health Care

    EVP & Chief Legal Officer Zaetta Christopher R covered exercise/tax liability with 134 shares, decreasing direct ownership by 0.80% to 16,582 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    6/4/26 4:26:43 PM ET
    $UNH
    Medical Specialities
    Health Care

    Chief Executive Officer, Optum Conway Patrick Hugh covered exercise/tax liability with 204 shares, decreasing direct ownership by 1% to 17,601 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    6/4/26 4:25:42 PM ET
    $UNH
    Medical Specialities
    Health Care

    Chief Executive Officer, Optum Conway Patrick Hugh sold $284,000 worth of shares (800 units at $355.00), decreasing direct ownership by 4% to 17,805 units (SEC Form 4)

    4 - UNITEDHEALTH GROUP INC (0000731766) (Issuer)

    4/27/26 4:50:58 PM ET
    $UNH
    Medical Specialities
    Health Care

    $CHNG
    $UNH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

    UnitedHealth Group (NYSE:UNH) provided updates on its 2026 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Scott Gottlieb, M.D., Stephen Hemsley, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting any Board Chair to be independent. At its regular quarterly meeting, the Board of Directors autho

    6/3/26 7:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealthcare Eliminates Nearly Two-Thirds of Prior Authorization Requirements for Pediatric Care

    Initiative follows a series of concrete actions in 2026 to make healthcare easier for everyone to navigate UnitedHealthcare is removing two-thirds of authorization requirements for members under age 18 by year's end. This move is the latest in a series of initiatives to simplify the healthcare system for providers and patients. The company is eliminating prior authorizations for many diagnostic services, routine surgical procedures and specialty care services across pediatric subspecialties such as cardiology, neurology, pulmonology and orthopedics. UnitedHealthcare is also introducing authorization waivers for certain procedures performed at leading comprehensive pediatric hospitals,

    5/29/26 7:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealthcare Community Plan of D.C. Earns NCQA LTSS Distinction

    UnitedHealthcare Community Plan of D.C. has earned the Long-Term Services and Supports (LTSS) Distinction by the National Committee for Quality Assurance (NCQA). NCQA is a private, non-profit organization dedicated to improving health care quality. NCQA's LTSS Distinction offers a person-centered, comprehensive and standardized evaluation of organizations responsible for delivering managed long-term services and supports. LTSS Distinction is specifically designed for organizations that coordinate both medical care and LTSS for their members. Achieving this distinction strengthens operational efficiency; enhances communication among individuals, caregivers, providers and payers; and reduce

    5/18/26 8:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    $CHNG
    $UNH
    Financials

    Live finance-specific insights

    View All

    UnitedHealth Group Updates on Annual Shareholder Meeting, Board Actions

    UnitedHealth Group (NYSE:UNH) provided updates on its 2026 annual shareholder meeting and actions taken by its Board of Directors. Shareholders re-elected current directors: Charles Baker, Timothy Flynn, Paul Garcia, Kristen Gil, Scott Gottlieb, M.D., Stephen Hemsley, F. William McNabb III, Valerie Montgomery Rice, M.D. and John Noseworthy, M.D. Shareholders also: Approved the advisory resolution on the Company's executive compensation. Ratified Deloitte & Touche LLP as the Company's independent registered public accounting firm. Voted against the shareholder proposal requesting any Board Chair to be independent. At its regular quarterly meeting, the Board of Directors autho

    6/3/26 7:00:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Reports First Quarter 2026 Results

    First Quarter 2026 Revenues of $111.7 Billion Grew 2% Year-over-Year Earnings of $6.90 Per Share and Adjusted Earnings of $7.23 Per Share Full Year 2026 Earnings Outlook Raised to Greater Than $17.35 Per Share; Adjusted Earnings of Greater Than $18.25 Per Share To view this information in a different format, including graphics, published on our website, click here: https://www.unitedhealthgroup.com/content/dam/UHG/PDF/investors/2026/unh-reports-first-quarter-2026-results.pdf UnitedHealth Group (NYSE:UNH) today reported first quarter 2026 results, with performance supported by actions taken over the last several quarters. This press release features multimedia. View the full rel

    4/21/26 5:55:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    UnitedHealth Group Board Authorizes Payment of Quarterly Dividend

    The UnitedHealth Group (NYSE:UNH) board of directors has authorized payment of a cash dividend of $2.21 per share, to be paid on March 17, 2026, to all shareholders of record of UNH common stock as of the close of business March 9, 2026. About UnitedHealth Group UnitedHealth Group (NYSE:UNH) is a health care and well-being company with a mission to help people live healthier lives and help make the health system work better for everyone through two distinct and complementary businesses. Optum delivers care aided by technology and data, empowering people, partners and providers with the guidance and tools they need to achieve better health. UnitedHealthcare offers a full range of health

    2/25/26 6:50:00 AM ET
    $UNH
    Medical Specialities
    Health Care

    $CHNG
    $UNH
    Leadership Updates

    Live Leadership Updates

    View All

    Twilio Set to Join S&P MidCap 400

    NEW YORK, Aug. 14, 2025 /PRNewswire/ -- Twilio Inc. (NYSE:TWLO) will replace Amedisys Inc. (NASD: AMED) in the S&P MidCap 400 effective prior to the opening of trading on Tuesday, August 19. S&P 500 and S&P 100 constituent UnitedHealth Group Inc. (NYSE:UNH) acquired Amedisys in a deal completed today. Following is a summary of the changes that will take place prior to the open of trading on the effective date: Effective Date Index Name       Action Company Name Ticker GICS Sector August 19, 2025 S&P MidCap 400 Addition Twilio TWLO Information Technology August 19, 2025 S&P MidCap 400 Deletion Amedisys AMED Health Care For more information about S&P Dow Jones Indices, please visit www.spdji

    8/14/25 6:08:00 PM ET
    $AMED
    $SPGI
    $TWLO
    Medical/Nursing Services
    Health Care
    Finance: Consumer Services
    Finance

    UnitedHealth Group Investors: Please contact the Portnoy Law Firm to recover your losses. July 7, 2025 Deadline to file Lead Plaintiff Motion.

    Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, May 13, 2025 (GLOBE NEWSWIRE) --  The Portnoy Law Firm advises UnitedHealth Group ("UnitedHealth" or the "Company") (NYSE:UNH) UnitedHealth investors have until July 7, 2025 to file a lead plaintiff motion. Investors are encouraged to contact attorney Lesley F. Portnoy, by phone 310-692-8883 or email: lesley@portnoylaw.com, to discuss their legal rights, or click here to join the case. The Portnoy Law Firm can provide a complimentary case evaluation and discuss investors' options for pursuing claims to recover their losses. UnitedHealth is a health insurance and health care services pr

    5/13/25 5:59:56 PM ET
    $UNH
    Medical Specialities
    Health Care

    Charlie Baker Joins UnitedHealth Group's Board of Directors

    UnitedHealth Group (NYSE:UNH) announced Charlie Baker, the former governor of Massachusetts and a prominent former health care executive, has been appointed to its Board of Directors, effective immediately. "Charlie Baker's leadership and deep health care experience will serve UnitedHealth Group well in its efforts to make the health system work better for everyone," said UnitedHealth Group Board Chairman Stephen J. Hemsley. "Charlie is an outstanding addition to our board given his proven track record in government and in leading businesses in the health sector, including care delivery and benefits." "UnitedHealth Group has unique capabilities to improve health care outcomes, lower cos

    11/3/23 4:00:00 PM ET
    $UNH
    Medical Specialities
    Health Care

    $CHNG
    $UNH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/13/24 5:16:09 PM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/24 10:05:20 AM ET
    $UNH
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by UnitedHealth Group Incorporated (Amendment)

    SC 13G/A - UNITEDHEALTH GROUP INC (0000731766) (Subject)

    2/9/23 12:39:51 PM ET
    $UNH
    Medical Specialities
    Health Care